News overview

Indication of COVID-19 hyperimmune immunoglobulin for prophylaxis and therapy

Virtual HED & ASH review date known, save the date!

The new priority list is out. Because the HOVON carries out many different studies, we understand that it can sometimes be difficult to determine the priority between studies. With this list we hope t...

Welcome to our new HOVON website! Please find a message from our HOVON chair Prof. J.J. Cornelissen below.